Europe In Vivo Preclinical Brain Imaging Devices Market - Industry Trends and Forecast to 2032

Description

List of Tables

The Europe in vivo preclinical brain imaging devices market is expected to reach USD 232,722.54 thousand by 2030 from USD 151,370.83 thousand in 2022, growing at a CAGR of 5.6% in the forecast period of 2023 to 2030.

Market Segmentation

Europe In Vivo Preclinical Brain Imaging Devices Market, By Imaging Modality Type (MRI, PET/SPECT, CT, Optical Miniscopes, 2Photon Confocal, US, NIR Fluorescence, OCT, Bioluminescence, and Others), Application (Drug Discovery, Disease Characterization, and Toxicology), Therapeutic Area (Alzheimer's Disease, Parkinson's Disease, Oncology, and Other Therapeutic Areas), Biological Variable (BOLD, Oxygenation, Blood Flow, Microvessels, Neuronal Activity, and Soft Tissue), Temporal Format of Use (Under an Hour, Many Hours, and Longitudinal) End User (Pharma-Inhouse, CRO, Academia, and Others), Country (Germany, France, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, and Rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe In Vivo Preclinical Brain Imaging Devices Market Dynamics

Driver
Rising prevalence of neurological disorder
Restraint
Ethical and regulatory consideration
Opportunity
Rising research and development activities

Market Players

The key market players operating in the Europe in vivo preclinical brain imaging devices market are:

Bruker
PerkinElmer Inc.
FUJIFILM Corporation
Miltenyi Biotec
Charles River Laboratories.
Hologic, Inc.
LI-COR, Inc.
MILabs B.V.
TriFoil Imaging
Berthold Technologies GmbH & Co.KG
A14R
Aspect Imaging Ltd.
Cubresa Inc.
Mediso Ltd.
MR Solutions
Spectrum Instruments Imaging

1 INTRODUCTION 16

1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 16
1.4 CURRENCY AND PRICING 17
1.5 LIMITATIONS 18
1.6 MARKETS COVERED 18

2 MARKET SEGMENTATION 20

2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 DBMR TRIPOD DATA VALIDATION MODEL 23
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.6 MULTIVARIATE MODELLING 27
2.7 IMAGING MODALITY TYPE SEGMENT LIFELINE CURVE 27
2.8 MARKET END USER COVERAGE GRID 28
2.9 DBMR MARKET POSITION GRID 29
2.10 VENDOR SHARE ANALYSIS 31
2.11 SECONDARY SOURCES 32
2.12 ASSUMPTIONS 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 36

4.1 PESTEL ANALYSIS 37
4.2 PORTR'S FIVE FORCES 38

5 REGULATORY FRAMEWORK 39

5.1 REGULATORY SCENARIO IN U.S. 39
5.2 REGULATORY SCENARIO IN AUSTRALIA 39
5.3 REGULATORY SCENARIO IN EUROPE 40
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 40
5.5 REGULATORY SCENARIO IN BRAZIL 40

6 MARKET OVERVIEW 41

6.1 DRIVERS 43
- 6.1.1 RISING PREVALENCE OF NEUROLOGICAL DISORDERS 43
- 6.1.2 ADVANCEMENTS IN IMAGING TECHNIQUES USED IN BRAIN IMAGING 43
- 6.1.3 INCREASING ADOPTION OF IN-VIVO IMAGING SYSTEMS 44
6.2 RESTRAINTS 44
- 6.2.1 ETHICAL AND REGULATORY CONSIDERATIONS 44
- 6.2.2 HIGH COST ASSOCIATED WITH BRAIN IMAGING EQUIPMENT 44
6.3 OPPORTUNITIES 45
- 6.3.1 RISING STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS 45
- 6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES 45
6.4 CHALLENGES 46
- 6.4.1 LACK OF SKILLED PROFESSIONALS DUE TO TECHNOLOGY ADVANCEMENT 46
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 47

7 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE 48

7.1 OVERVIEW 49
7.2 MRI 50
7.3 PET/SPECT 51
7.4 CT 51
7.5 OPTICAL MINISCOPES 52
7.6 2 PHOTON CONFOCAL 52
7.7 US 53
7.8 NIR FLUORESCENCE 53
7.9 OCT 54
7.10 BIOLUMINESCENCE 54
7.11 OTHERS 55

8 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION 56

8.1 OVERVIEW 57
8.2 DRUG DISCOVERY 58
- 8.2.1 PRECLINICAL STUDIES 59
- 8.2.2 EARLY DRUG DISCOVERY 59
- 8.2.3 CLINICAL DEVELOPMENT 59
- 8.2.4 POST MARKET MONITORING 59
- 8.2.5 DATA REVIEW 59
8.3 DISEASE CHARACTERIZATION 59
8.4 TOXICOLOGY 60

9 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA 61

9.1 OVERVIEW 62
9.2 ALZHEIMER'S DISEASE 63
9.3 PARKINSON'S DISEASE 64
9.4 ONCOLOGY 64
9.5 OTHER THERAPEUTIC AREAS 65

10 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 66

10.1 OVERVIEW 67
10.2 BOLD 68
10.3 OXYGENATION 69
10.4 BLOOD FLOW 69
10.5 MICROVESSELS 70
10.6 NEURONAL ACTIVITY 70
10.7 SOFT TISSUE 71

11 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE 72

11.1 OVERVIEW 73
11.2 UNDER AN HOUR 74
11.3 MANY HOURS 75
11.4 LONGITUDINAL 75

12 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER 76

12.1 OVERVIEW 77
12.2 PHARMA-INHOUSE 78
12.3 CRO 79
12.4 ACADEMIA 79
12.5 OTHERS 80

13 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION 81

13.1 EUROPE 82

14 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, COMPANY LANDSCAPE 106

14.1 COMPANY SHARE ANALYSIS: EUROPE 106

15 SWOT ANALYSIS 107

16 COMPANY PROFILE 108

16.1 BRUKER 108
- 16.1.1 COMPANY SNAPSHOT 108
- 16.1.2 REVENUE ANALYSIS 108
- 16.1.3 COMPANY SHARE ANALYSIS 109
- 16.1.4 PRODUCT PORTFOLIO 109
- 16.1.5 RECENT DEVELOPMENT 109
16.2 PERKINELMER INC. 110
- 16.2.1 COMPANY SNAPSHOT 110
- 16.2.2 REVENUE ANALYSIS 110
- 16.2.3 COMPANY SHARE ANALYSIS 111
- 16.2.4 PRODUCT PORTFOLIO 111
- 16.2.5 RECENT DEVELOPMENT 111
16.3 FUJIFILM CORPORATION 112
- 16.3.1 COMPANY SNAPSHOT 112
- 16.3.2 REVENUE ANALYSIS 112
- 16.3.3 COMPANY SHARE ANALYSIS 113
- 16.3.4 PRODUCT PORTFOLIO 113
- 16.3.5 RECENT DEVELOPMENT 113
16.4 MILTENYI BIOTEC 114
- 16.4.1 COMPANY SNAPSHOT 114
- 16.4.2 COMPANY SHARE ANALYSIS 114
- 16.4.3 PRODUCT PORTFOLIO 115
- 16.4.4 RECENT DEVELOPMENT 115
16.5 CHARLES RIVER LABORATORIES. 116
- 16.5.1 COMPANY SNAPSHOT 116
- 16.5.2 REVENUE ANALYSIS 116
- 16.5.3 COMPANY SHARE ANALYSIS 117
- 16.5.4 PRODUCT PORTFOLIO 117
- 16.5.5 RECENT DEVELOPMENT 117
16.6 AI4R 118
- 16.6.1 COMPANY SNAPSHOT 118
- 16.6.2 PRODUCT PORTFOLIO 118
- 16.6.3 RECENT DEVELOPMENT 118
16.7 ASPECT IMAGING LTD. 119
- 16.7.1 COMPANY SNAPSHOT 119
- 16.7.2 PRODUCT PORTFOLIO 119
- 16.7.3 RECENT DEVELOPMENT 119
16.8 BERTHOLD TECHNOLOGIES GMBH & CO.KG 120
- 16.8.1 COMPANY SNAPSHOT 120
- 16.8.2 PRODUCT PORTFOLIO 120
- 16.8.3 RECENT DEVELOPMENT 120
16.9 CUBRESA INC. 121
- 16.9.1 COMPANY SNAPSHOT 121
- 16.9.2 PRODUCT PORTFOLIO 121
- 16.9.3 RECENT DEVELOPMENT 121
16.10 HOLOGIC, INC. 122
- 16.10.1 COMPANY SNAPSHOT 122
- 16.10.2 REVENUE ANALYSIS 122
- 16.10.3 PRODUCT PORTFOLIO 123
- 16.10.4 RECENT DEVELOPMENT 123
16.11 LI-COR, INC. 124
- 16.11.1 COMPANY SNAPSHOT 124
- 16.11.2 PRODUCT PORTFOLIO 124
- 16.11.3 RECENT DEVELOPMENT 124
16.12 MEDISO LTD. 125
- 16.12.1 COMPANY SNAPSHOT 125
- 16.12.2 PRODUCT PORTFOLIO 125
- 16.12.3 RECENT DEVELOPMENT 125
16.13 MILABS B.V. 126
- 16.13.1 COMPANY SNAPSHOT 126
- 16.13.2 PRODUCT PORTFOLIO 126
- 16.13.3 RECENT DEVELOPMENT 126
16.14 MR SOLUTIONS 127
- 16.14.1 COMPANY SNAPSHOT 127
- 16.14.2 PRODUCT PORTFOLIO 127
- 16.14.3 RECENT DEVELOPMENT 127
16.15 SPECTRAL INSTRUMENTS IMAGING 128
- 16.15.1 COMPANY SNAPSHOT 128
- 16.15.2 PRODUCT PORTFOLIO 128
- 16.15.3 RECENT DEVELOPMENT 128
16.16 TRIFOIL IMAGING 129
- 16.16.1 COMPANY SNAPSHOT 129
- 16.16.2 PRODUCT PORTFOLIO 129
- 16.16.3 RECENT DEVELOPMENT 129

17 QUESTIONNAIRE 130

18 RELATED REPORTS 133

LIST OF TABLES

TABLE 1 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 50
TABLE 2 EUROPE MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 50
TABLE 3 EUROPE PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 4 EUROPE CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 51
TABLE 5 EUROPE OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 6 EUROPE 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 52
TABLE 7 EUROPE US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 8 EUROPE NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 53
TABLE 9 EUROPE OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 54
TABLE 10 EUROPE BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 54
TABLE 11 EUROPE OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 55
TABLE 12 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 58
TABLE 13 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
TABLE 14 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 58
TABLE 15 EUROPE DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 59
TABLE 16 EUROPE TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 60
TABLE 17 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 63
TABLE 18 EUROPE ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 63
TABLE 19 EUROPE PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 20 EUROPE ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 21 EUROPE OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
TABLE 22 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 68
TABLE 23 EUROPE BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 24 EUROPE OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 25 EUROPE BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 26 EUROPE MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 27 EUROPE NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 28 EUROPE SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 29 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 74
TABLE 30 EUROPE UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 74
TABLE 31 EUROPE MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 32 EUROPE LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 75
TABLE 33 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 78
TABLE 34 EUROPE PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 35 EUROPE CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 36 EUROPE ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 37 EUROPE OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 38 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 82
TABLE 39 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 40 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 83
TABLE 41 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 42 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 83
TABLE 43 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND) 83
TABLE 44 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 84
TABLE 45 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 84
TABLE 46 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 47 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 85
TABLE 48 GERMANY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 49 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 86
TABLE 50 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 86
TABLE 51 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 86
TABLE 52 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 86
TABLE 53 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 54 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 87
TABLE 55 FRANCE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 87
TABLE 56 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 88
TABLE 57 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 88
TABLE 58 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 88
TABLE 59 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 88
TABLE 60 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 61 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 89
TABLE 62 U.K. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 89
TABLE 63 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 90
TABLE 64 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 90
TABLE 65 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 90
TABLE 66 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 90
TABLE 67 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 68 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 91
TABLE 69 ITALY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 70 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 92
TABLE 71 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 92
TABLE 72 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 92
TABLE 73 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 92
TABLE 74 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 93
TABLE 75 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 93
TABLE 76 SPAIN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 93
TABLE 77 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 94
TABLE 78 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 94
TABLE 79 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 94
TABLE 80 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 94
TABLE 81 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 95
TABLE 82 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 95
TABLE 83 RUSSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
TABLE 84 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 96
TABLE 85 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 96
TABLE 86 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 96
TABLE 87 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
TABLE 88 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 89 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
TABLE 90 TURKEY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 91 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 98
TABLE 92 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 98
TABLE 93 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 98
TABLE 94 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
TABLE 95 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 96 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 99
TABLE 97 BELGIUM DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 98 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 100
TABLE 99 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 100
TABLE 100 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 100
TABLE 101 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 100
TABLE 102 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 103 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 101
TABLE 104 NETHERLANDS DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 105 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 102
TABLE 106 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 102
TABLE 107 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 102
TABLE 108 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 109 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 110 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 103
TABLE 111 SWITZERLAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 112 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND) 104
TABLE 113 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND) 104
TABLE 114 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND) 104
TABLE 115 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND) 104
TABLE 116 REST OF EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND) 105

LIST OF FIGURES

FIGURE 1 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 20
FIGURE 2 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DATA TRIANGULATION 23
FIGURE 3 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DROC ANALYSIS 24
FIGURE 4 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 25
FIGURE 5 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 25
FIGURE 6 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 26
FIGURE 7 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: MARKET END USERS COVERAGE GRID 28
FIGURE 8 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: DBMR MARKET POSITION GRID 29
FIGURE 9 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: VENDOR SHARE ANALYSIS 31
FIGURE 10 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: SEGMENTATION 35
FIGURE 11 RISING PREVALENCE OF NEUROLOGICAL DISORDER IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET FROM 2023 TO 2030 36
FIGURE 12 IMAGING MODALITY TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET IN 2023 & 2030 36
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET 42
FIGURE 14 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY IMAGING MODALITY TYPE, 2022 49
FIGURE 15 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY APPLICATION, 2022 57
FIGURE 16 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY THERAPEUTIC AREA, 2022 62
FIGURE 17 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY BIOLOGICAL VARIABLE, 2022 67
FIGURE 18 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY TEMPORAL FORMAT OF USE, 2022 73
FIGURE 19 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: BY END USER, 2022 77
FIGURE 20 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET: COMPANY SHARE 2022 (%) 106